T. Rowe Price Associates’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400K | Buy |
43,762
+4,595
| +12% | +$42K | ﹤0.01% | 2406 |
|
|
2025
Q1 | $312K | Sell |
39,167
-375,054
| -91% | -$2.99M | ﹤0.01% | 2455 |
|
|
2024
Q4 | $2.25M | Sell |
414,221
-36,416
| -8% | -$198K | ﹤0.01% | 1585 |
|
|
2024
Q3 | $3.25M | Sell |
450,637
-62,200
| -12% | -$449K | ﹤0.01% | 1428 |
|
|
2024
Q2 | $5.57M | Sell |
512,837
-299,097
| -37% | -$3.25M | ﹤0.01% | 1198 |
|
|
2024
Q1 | $15.2M | Buy |
811,934
+333,805
| +70% | +$6.26M | ﹤0.01% | 1037 |
|
|
2023
Q4 | $10.4M | Sell |
478,129
-104,143
| -18% | -$2.26M | ﹤0.01% | 1083 |
|
|
2023
Q3 | $12M | Sell |
582,272
-497,881
| -46% | -$10.2M | ﹤0.01% | 1034 |
|
|
2023
Q2 | $50.8M | Sell |
1,080,153
-828,238
| -43% | -$38.9M | 0.01% | 701 |
|
|
2023
Q1 | $80.1M | Buy |
1,908,391
+11,069
| +0.6% | +$464K | 0.01% | 561 |
|
|
2022
Q4 | $72.4M | Sell |
1,897,322
-243,089
| -11% | -$9.27M | 0.01% | 564 |
|
|
2022
Q3 | $83.8M | Buy |
2,140,411
+62,877
| +3% | +$2.46M | 0.01% | 520 |
|
|
2022
Q2 | $67.1M | Sell |
2,077,534
-80,970
| -4% | -$2.62M | 0.01% | 786 |
|
|
2022
Q1 | $71.4M | Buy |
2,158,504
+741,982
| +52% | +$24.6M | 0.01% | 844 |
|
|
2021
Q4 | $60.3M | Buy |
1,416,522
+9,633
| +0.7% | +$410K | 0.01% | 941 |
|
|
2021
Q3 | $62.3M | Sell |
1,406,889
-164,664
| -10% | -$7.3M | 0.01% | 936 |
|
|
2021
Q2 | $89.3M | Sell |
1,571,553
-835,294
| -35% | -$47.5M | 0.01% | 830 |
|
|
2021
Q1 | $180M | Buy |
2,406,847
+49,505
| +2% | +$3.71M | 0.02% | 583 |
|
|
2020
Q4 | $204M | Sell |
2,357,342
-201,692
| -8% | -$17.4M | 0.02% | 529 |
|
|
2020
Q3 | $156M | Sell |
2,559,034
-260,018
| -9% | -$15.9M | 0.02% | 541 |
|
|
2020
Q2 | $117M | Sell |
2,819,052
-145,256
| -5% | -$6.04M | 0.01% | 590 |
|
|
2020
Q1 | $85.1M | Sell |
2,964,308
-2,684,880
| -48% | -$77.1M | 0.01% | 617 |
|
|
2019
Q4 | $408M | Sell |
5,649,188
-1,814,263
| -24% | -$131M | 0.05% | 334 |
|
|
2019
Q3 | $1.05B | Sell |
7,463,451
-440,833
| -6% | -$61.8M | 0.15% | 151 |
|
|
2019
Q2 | $1.45B | Sell |
7,904,284
-409,431
| -5% | -$75M | 0.2% | 120 |
|
|
2019
Q1 | $1.32B | Buy |
8,313,715
+293,304
| +4% | +$46.6M | 0.19% | 120 |
|
|
2018
Q4 | $768M | Buy |
8,020,411
+267,777
| +3% | +$25.7M | 0.13% | 161 |
|
|
2018
Q3 | $1.1B | Buy |
7,752,634
+120,205
| +2% | +$17M | 0.16% | 143 |
|
|
2018
Q2 | $1.19B | Buy |
7,632,429
+476,305
| +7% | +$74.6M | 0.18% | 125 |
|
|
2018
Q1 | $1.15B | Buy |
7,156,124
+844,807
| +13% | +$136M | 0.18% | 123 |
|
|
2017
Q4 | $1.04B | Buy |
6,311,317
+1,643,958
| +35% | +$271M | 0.17% | 136 |
|
|
2017
Q3 | $291M | Buy |
4,667,359
+1,128,486
| +32% | +$70.3M | 0.05% | 364 |
|
|
2017
Q2 | $282M | Buy |
3,538,873
+205,683
| +6% | +$16.4M | 0.05% | 358 |
|
|
2017
Q1 | $237M | Buy |
3,333,190
+774,857
| +30% | +$55.1M | 0.04% | 392 |
|
|
2016
Q4 | $131M | Buy |
2,558,333
+1,156,655
| +83% | +$59.1M | 0.03% | 523 |
|
|
2016
Q3 | $64.5M | Buy |
1,401,678
+930,608
| +198% | +$42.9M | 0.01% | 709 |
|
|
2016
Q2 | $14.2M | Buy |
471,070
+89,545
| +23% | +$2.7M | ﹤0.01% | 1209 |
|
|
2016
Q1 | $12.2M | Hold |
381,525
| – | – | ﹤0.01% | 1225 |
|
|
2015
Q4 | $22.2M | Sell |
381,525
-349,985
| -48% | -$20.4M | ﹤0.01% | 1048 |
|
|
2015
Q3 | $31M | Buy |
731,510
+313,583
| +75% | +$13.3M | 0.01% | 947 |
|
|
2015
Q2 | $30.5M | Buy |
417,927
+328,049
| +365% | +$23.9M | 0.01% | 1005 |
|
|
2015
Q1 | $4.52M | Buy |
+89,878
| New | +$4.52M | ﹤0.01% | 1485 |
|